Key result
Obesity linked to ~30% higher odds of electrical cardioversion for AF, but not ablation.
Why the study?
Obesity is a significant risk factor for cardiovascular conditions and AF prevalence is elevated with obesity, but its influence on AF outcomes and management modalities required evaluation.
Does obesity increase the likelihood of undergoing electrical cardioversion or cardiac ablation in hospitalized adult patients with atrial fibrillation?
Cohort (n=1,625,809)
Yes
Does obesity increase the likelihood of undergoing electrical cardioversion or cardiac ablation in hospitalized adult patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Higher BMI is significantly associated with an increased likelihood of undergoing electrical cardioversion, but not cardiac ablation, in hospitalized patients with atrial fibrillation.
Background Obesity is considered a significant risk factor for numerous cardiovascular conditions. The prevalence of atrial fibrillation (AF) is elevated among patients with obesity. Weight loss has been shown to reverse cardiac remodelling, leading to lower recurrence of AF despite the better prognosis in obese patients. Methods We utilized the National Inpatient Sample 2016-2019 to extract patients ≥18 years of age admitted with AF as the primary diagnosis based on ICD 10 codes. We performed univariate and multivariate regression analysis for known coronary risk factors. We divided patients based on their body mass index (BMI), and our primary outcomes were determining the odds of electrical cardioversion (ECV) and cardiac ablation (CA) due to AF. Results The analysis included 1,625,809 weighted patients. Patients include underweight (6.66%), normal BMI (4.03), overweight (6.51%), obesity class I (20.65%), obesity class II (21.45%), and obesity class III (40.7). After multivariate regression analysis, patients with obesity class I, II, or III had higher odds of ECV, irrespectively of coronary risk factors (OR 1.3, 95% CI 1.25-1.37, OR 1.3, 95% CI 1.32-1.43, OR 1.3, 95% CI1.29-1.38, respectively, with statistically significant P values). However, underweight or normal BMI patients had fewer odds of ECV (OR 0.5 95%CI 0.49-0.61 and OR 0.6 95%CI 0.58-0.74, respectively, with P values <0.001). Meanwhile, there was no statistical significance between a BMI and the odds of CA. Conclusion Our study highlights the significant impact of BMI on managing AF, particularly regarding ECV. Patients in higher BMI categories (obesity class I to III) had increased odds of undergoing ECV, suggesting obesity influences treatment approaches and outcomes in AF management. Interestingly, BMI did not affect the likelihood of CA, indicating a complex relationship between body weight and AF treatment modalities warranting further investigation.
No takes yet. Share an insight, caveat, or question.
Argueta et al. (2025) conducted a cohort in Atrial fibrillation (n=1,625,809). Obesity (Body Mass Index) vs. Normal BMI was evaluated on Electrical cardioversion (OR 1.3, 95% CI 1.25-1.37, p=<0.001). Obesity classes I, II, and III were associated with significantly increased odds of undergoing electrical cardioversion for atrial fibrillation (OR 1.3, p<0.001) compared to normal BMI, while BMI did not affect the likelihood of cardiac ablation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: